Study of Patient Satisfaction With the Cancer Clinical Trial Experience

May 22, 2012 updated by: Joyce Neading, Summa Health System

The primary objective of this study is to evaluate the quality of the clinical trial experience of cancer patients participating in cancer research studies through Summa Health System Hospitals Cancer Research Program by evaluating patient satisfaction regarding reasons for participating, facility, consent and treatment, personal issues and overall assessment.

The secondary objective of this study is to determine areas for improvement to make the patient's clinical trial experience a satisfying and positive journey.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

100

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Participant must have participated in a clinical trial conducted by the Summa Health System Hospitals Cancer Research Program.

Description

Inclusion Criteria:

  • Participant must have participated in a clinical trial conducted by the Summa Health System Hospitals Cancer Research Program.
  • Participant should have been registered for clinical trial participation three months prior to receiving the satisfaction survey.

Exclusion Criteria:

  • Participant has withdrawn consent for clinical trial participation and/or follow up.
  • Participant has a major medical illness that would prevent completion of the survey.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Evaluation of surveys to determine if there are opportunities for performance and/or quality improvement projects.patient satisfaction regarding reasons for participating, facility, consent and treatment, personal issues and overall assessment.
Time Frame: Survey will be sent to subject 3 months after study registration
Survey will be sent to subject 3 months after study registration

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Summa Health System

Investigators

  • Principal Investigator: Joyce Neading, RHIT, CTR, Summa Health System

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2008

Primary Completion (Actual)

May 1, 2012

Study Completion (Actual)

May 1, 2012

Study Registration Dates

First Submitted

October 7, 2008

First Submitted That Met QC Criteria

October 7, 2008

First Posted (Estimate)

October 8, 2008

Study Record Updates

Last Update Posted (Estimate)

May 23, 2012

Last Update Submitted That Met QC Criteria

May 22, 2012

Last Verified

May 1, 2012

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Clinical trial experience

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe